The global market for active pharmaceutical ingredients (API) has been growing steadily in recent years. Though the economic recession of 2008-2009 affected the growth of the market, nevertheless, the market has bounced back with strong growth since then. However, the industry is today facing a record number of blockbuster drugs going off patent. This is having a major impact on the global API industry as revenues of the API markets are being affected as generic drugs have started to make their presence felt on the market.
The United States remains one of the biggest players in the market, followed closely by China and India. Synthetic pharmaceuticals also continue to dominate the API industry as biotech APIs move up slowly. Major companies such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the leading players in the global active pharmaceutical ingredient market.
The publisher analyzes the global API industry in its research report Analyzing the Global Market for Active Pharmaceutical Ingredients 2018. The report begins with an introduction to active pharmaceutical ingredients (APIs). An analysis of the global market for APIs includes an industry overview, industry revenues, industry segmentation by the biotech API market and the Synthetic API market and a profile of the High Potency Active Pharmaceutical Ingredient (HPAPAI) Market. We also analyze some of the major impacts on the global API market such as the ongoing and few upcoming patent expiries of blockbuster drugs.
An analysis of the market for APIs in Asia Pacific is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Asia Pacific and the impacts on the industry. Key markets analyzed in Asia Pacific include China, India, Japan and South Korea.
An analysis of the market for APIs in Europe is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in Europe and the impacts on the industry. Key markets analyzed in Europe include France, Germany, Italy, Spain and the United Kingdom.
An analysis of the market for APIs in North America is carried out through an industry overview, analysis of industry revenues and industry segmentation, the therapeutic applications of APIs in North America and the impacts on the industry. Key markets analyzed in North America include Canada and the United States.
An analysis of the major industry players such as Teva, Albemarle, Allergan, Boehringer, Cipla and others is carried out through an analysis of their business profile, major products & services, and a SWOT analysis. This in-depth report on the Global Market for Active Pharmaceutical Ingredients 2018 is a comprehensive profile of this industry.
Table of Contents
A. Executive Summary
B. Introduction to Active Pharmaceutical Ingredients
C. Global Market for Active Pharmaceutical Ingredients (APIs)
C.1 Industry Overview
C.2 Industry Revenues
C.3 Industry Segmentation
C.3.1 Biotech API Market
C.3.2 Synthetic API Market
C.4 Brief Profile: High Potency Active Pharmaceutical Ingredients (HPAPIs)
D. Impacts on the Global API Market
D.1 Impact of the Economic Recession
D.2 Impact of Patent Expiries & Growing Uptake of Biologics
D.3 Increased Price Competition & Price Cuts by Governments
D.4 Growing Number of Mergers & Acquisitions & Increased Global Coverage
D.5 Regulatory Framework
E. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific
E.1 Industry Overview
E.2 Industry Revenues
E.3 Industry Segmentation
E.3.1 Biotech API Market
E.3.2 Synthetic API Market
E.4 Therapeutic Applications of API in Asia Pacific
E.5 Impacts on the Industry
F. Market for Active Pharmaceutical Ingredients (APIs) in China
F.1 Industry Overview
F.2 Industry Revenues
F.3 Industry Segmentation
F.3.1 Biotech API Market
F.3.2 Synthetic API Market
G. Market for Active Pharmaceutical Ingredients (APIs) in India
G.1 Industry Overview
G.2 Industry Revenues
G.3 Industry Segmentation
G.3.1 Biotech API Market
G.3.2 Synthetic API Market
H. Market for Active Pharmaceutical Ingredients (APIs) in Japan
H.1 Industry Overview
H.2 Industry Revenues
H.3 Industry Segmentation
H.3.1 Biotech API Market
H.3.2 Synthetic API Market
I. Market for Active Pharmaceutical Ingredients (APIs) in South Korea
I.1 Industry Overview
I.2 Industry Revenues
I.3 Industry Segmentation
I.3.1 Biotech API Market
I.3.2 Synthetic API Market
J. Market for Active Pharmaceutical Ingredients (APIs) in Europe
J.1 Industry Overview
J.2 Industry Revenues
J.3 Industry Segmentation
J.3.1 Biotech API Market
J.3.2 Synthetic API Market
J.4 Therapeutic Applications of API in Europe
J.5 Impacts on the Industry
K. Market for Active Pharmaceutical Ingredients (APIs) in France
K.1 Industry Overview
K.2 Industry Revenues
K.3 Industry Segmentation
K.3.1 Biotech API Market
K.3.2 Synthetic API Market
L. Market for Active Pharmaceutical Ingredients (APIs) in Germany
L.1 Industry Overview
L.2 Industry Revenues
L.3 Industry Segmentation
L.3.1 Biotech API Market
L.3.2 Synthetic API Market
M. Market for Active Pharmaceutical Ingredients (APIs) in Italy
M.1 Industry Overview
M.2 Industry Revenues
M.3 Industry Segmentation
M.3.1 Biotech API Market
M.3.2 Synthetic API Market
N. Market for Active Pharmaceutical Ingredients (APIs) in Spain
N.1 Industry Overview
N.2 Industry Revenues
N.3 Industry Segmentation
N.3.1 Biotech API Market
N.3.2 Synthetic API Market
O. Market for Active Pharmaceutical Ingredients (APIs) in United Kingdom
O.1 Industry Overview
O.2 Industry Revenues
O.3 Industry Segmentation
O.3.1 Biotech API Market
O.3.2 Synthetic API Market
P. Market for Active Pharmaceutical Ingredients (APIs) in North America
P.1 Industry Overview
P.2 Industry Revenues
P.3 Industry Segmentation
P.3.1 Biotech API Market
P.3.2 Synthetic API Market
P.4 Therapeutic Applications of API in North America
P.5 Impacts on the Industry
Q. Market for Active Pharmaceutical Ingredients (APIs) in Canada
Q.1 Industry Overview
Q.2 Industry Revenues
Q.3 Industry Segmentation
Q.3.1 Biotech API Market
Q.3.2 Synthetic API Market
R. Market for Active Pharmaceutical Ingredients (APIs) in the US
R.1 Industry Overview
R.2 Industry Revenues
R.3 Industry Segmentation
R.3.1 Biotech API Market
R.3.2 Synthetic API Market
S. Major Industry Players
S.1 Albemarle Corporation
S.1.1 Business Profile
S.1.2 Major Products & Services
S.1.3 SWOT Analysis
S.2 Allergan Plc
S.2.1 Business Profile
S.2.2 Major Products & Services
S.2.3 SWOT Analysis
S.3 BASF SE
S.3.1 Business Profile
S.3.2 Major Products & Services
S.3.3 SWOT Analysis
S.4 Boehringer Ingelheim GmbH
S.4.1 Business Profile
S.4.2 Major Products & Services
S.4.3 SWOT Analysis
S.5 Bristol Myers Squibb Company
S.5.1 Business Profile
S.5.2 Major Products & Services
S.5.3 SWOT Analysis
S.6 Koninklijke DSM N.V.
S.6.1 Business Profile
S.6.2 Major Products & Services
S.6.3 SWOT Analysis
S.7 Lonza Group AG
S.7.1 Business Profile
S.7.2 Major Products & Services
S.7.3 SWOT Analysis
S.8 Lupin Limited
S.8.1 Business Profile
S.8.2 Major Products & Services
S.8.3 SWOT Analysis
S.9 Novartis AG
S.9.1 Business Profile
S.9.2 Major Products & Services
S.9.3 SWOT Analysis
S.10 Pfizer Inc
S.10.1 Business Profile
S.10.2 Major Products & Services
S.10.3 SWOT Analysis
S.11 Sigma-Aldrich Corporation
S.11.1 Business Profile
S.11.2 Major Products & Services
S.11.3 SWOT Analysis
S.12 Teva Pharmaceutical Industries Limited
S.12.1 Business Profile
S.12.2 Major Products & Services
S.12.3SWOT Analysis
S.13 Ampac Fine Chemicals LLC
S.14 Aptuit, Inc
S.15 Aurobindo Pharma
S.16 Biocon Limited
S.17 Cambrex Corporation
S.18 Cipla Limited
S.19 Dishman Pharmaceuticals & Chemicals Ltd.
S.20 Dr. Reddy's Laboratories Limited
S.21 Fabbrica Italiana Sintetici
S.22 Medtronic Plc
S.23 Mylan Inc
S.24 Novasep Holding
S.25 Ranbaxy Laboratories
S.26 Sun Pharmaceutical Industries Limited
S.27 WuXi AppTec, Inc
T. Glossary of Terms
List of Figures
Figure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Figure 2: Global API Industry Segmentation by Revenues (%), 2017
Figure 3: Revenues of the Global Biotech API Market (in USD Million), 2008-2020
Figure 4: Share of the Global Biotech API Market by Regions (%), 2017
Figure 5: Share of Revenues of the Global Biotech API Market by Regions (%), 2008-2020
Figure 6: Share of the Global Biotech API Market by Application Sector (%), 2017
Figure 7: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2007-2020
Figure 8: Revenues of the Global Synthetic API Market (in USD Million), 2008-2020
Figure 9: Share of the Global Synthetic API Market by Regions (%), 2017
Figure 10: Share of Revenues of the Global Synthetic API Market by Regions (%), 2008-2020
Figure 11: Share of the Global Synthetic API Market by Application Sector (%), 2017
Figure 12: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2008-2020
Figure 13: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
Figure 14: Asia Pacific API Industry Segmentation by Revenues (%), 2017
Figure 15: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2008-2020
Figure 16: Share of the Biotech API Market in Asia Pacific by Countries (%), 2017
Figure 17: Performance & Growth of the Biotech API Market in Asia Pacific (%), 2008-2020
Figure 18: Share of Revenues of the Biotech API Market in Asia Pacific by Countries (%), 2008-2020
Figure 19: Share of the Biotech API Market in Asia Pacific by Application Sector (%), 2017
Figure 20: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2008-2020
Figure 21: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2008-2020
Figure 22: Share of the Synthetic API Market in Asia Pacific by Countries (%), 2017
Figure 23: Performance & Growth of the Synthetic API Market in Asia Pacific (%), 2008-2020
Figure 24: Share of Revenues by Countries in Asia Pacific Synthetic API Industry (%), 2008-2020
Figure 25: Share of the Synthetic API Market in Asia Pacific by Application Sector (%), 2017
Figure 26: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2008-2020
Figure 27: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
Figure 28: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2008-2020
Figure 29: China API Industry Segmentation by Revenues (%), 2008-2020
Figure 30: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2008-2020
Figure 31: Share of China Biotech API Market by Application Sector (%), 2008-2020
Figure 32: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2008-2020
Figure 33: Share of the Synthetic API Market in China by Application Sector (%), 2008-2020
Figure 34: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2008-2020
Figure 35: India API Industry Segmentation by Revenues (%), 2008-2020
Figure 36: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2008-2020
Figure 37: Share of the Biotech API Market in India by Application Sector (%), 2008-2020
Figure 38: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2008-2020
Figure 39: Share of the Synthetic API Market in India by Application Sector (%), 2008-2020
Figure 40: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2008-2020
Figure 41: Product Type & Revenue Share of the API Market in Japan (%), 2008-2020
Figure 42: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2008-2020
Figure 43: Share of the Biotech API Market in Japan by Application Sector (%), 2008-2020
Figure 44: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2008-2020
Figure 45: Share of the Synthetic API Market in Japan by Application Sector (%), 2008-2020
Figure 46: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2008-2020
Figure 47: South Korea API Industry Segmentation by Revenues (%), 2008-2020
Figure 48: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2008-2020
Figure 49: Share of the South Korea Biotech API Market by Application Sector (%), 2008-2020
Figure 50: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2008-2020
Figure 51: Share of the Synthetic API Market in South Korea by Application Sector (%), 2008-2020
Figure 52: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Figure 53: European API Industry Segmentation by Revenues (%), 2017
Figure 54: Revenues of the European Biotech API Market (in USD Million), 2008-2020
Figure 55: Share of the European Biotech API Market by Countries (%), 2017
Figure 56: Performance & Growth of the Biotech API Market in Europe (%), 2008-2020
Figure 57: Share of Revenues of the European Biotech API Market by Countries (%), 2008-2020
Figure 58: Share of the European Biotech API Market by Application Sector (%), 2017
Figure 59: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2008-2020
Figure 60: Revenues of the European Synthetic API Market (in USD Million), 2008-2020
Figure 61: Share of the European Synthetic API Market by Countries (%), 2017
Figure 62: Performance & Growth of the Synthetic API Market in Europe (%), 2008-2020
Figure 63: Share of Revenues of the Europe Synthetic API Market by Countries (%), 2008-2020
Figure 64: Share of the European Synthetic API Market by Application Sector (%), 2017
Figure 65: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2008-2020
Figure 66: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2017 & 2020
Figure 67: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2008-2020
Figure 68: France API Industry Segmentation by Revenues (%), 2008-2020
Figure 69: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2008-2020
Figure 70: Share of the Biotech API Market in France by Application Sector (%), 2008-2020
Figure 71: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2008-2020
Figure 72: Share of the Synthetic API Market in France by Application Sector (%), 2008-2020
Figure 73: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2008-2020
Figure 74: Revenue Share of the API Market in Germany by Product Type (%), 2008-2020
Figure 75: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2008-2020
Figure 76: Share of the Biotech API Market in Germany by Application Sector (%), 2008-2020
Figure 77: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2008-2020
Figure 78: Share of the Synthetic API Market in Germany by Application Sector (%), 2008-2020
Figure 79: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2008-2020
Figure 80: Italy API Industry Segmentation by Revenues (%), 2008-2020
Figure 81: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2008-2020
Figure 82: Share of the Biotech API Market in Italy by Application Sector (%), 2008-2020
Figure 83: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2008-2020
Figure 84: Share of the Synthetic API Market in Italy by Application Sector (%), 2008-2020
Figure 85: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2008-2020
Figure 86: Spain API Industry Segmentation by Revenues (%), 2008-2020
Figure 87: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2008-2020
Figure 88: Share of the Biotech API Market in Spain by Application Sector (%), 2008-2020
Figure 89: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2008-2020
Figure 90: Share of the Synthetic API Market in Spain by Application Sector (%), 2008-2020
Figure 91: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2008-2020
Figure 92: UK API Industry Segmentation by Revenues (%), 2008-2020
Figure 93: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2008-2020
Figure 94: Share of the Biotech API Market in UK by Application Sector (%), 2008-2020
Figure 95: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2008-2020
Figure 96: Share of the Synthetic API Market in UK by Application Sector (%), 2008-2020
Figure 97: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2008-2020
Figure 98: Industry Segmentation of the Active Pharmaceutical Ingredients (API) Market in North America by Revenues (%), 2008-2020
Figure 99: Revenues of the Biotech API Market in North America (in USD Million), 2008-2020
Figure 100: Share of the Biotech API Market in North America by Countries (%), 2017
Figure 101: Performance & Growth of the Biotech API Market in North America (%), 2008-2020
Figure 102: Share of Revenues of the Biotech API Market in North America by Countries (%), 2008-2020
Figure 103: Share of the Biotech API Market in North America by Application Sector (%), 2017
Figure 104: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2008-2020
Figure 105: Revenues of the Synthetic API Market in North America (in USD Million), 2008-2020
Figure 106: Share of the Synthetic API Market in North America by Countries (%), 2017
Figure 107: Performance & Growth of the Synthetic API Market in North America (%), 2008-2020
Figure 108: Share of Revenues by Countries in North America Synthetic API Industry (%), 2008-2020
Figure 109: Share of the Synthetic API Market in North America by Application Sector (%), 2017
Figure 110: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2008-2020
Figure 111: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2017 & 2020
Figure 112: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2008-2020
Figure 113: Revenue Share of the API Market in Canada by Industry Segments (%), 2008-2020
Figure 114: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2008-2020
Figure 115: Share of the Canada Biotech API Market by Application Sector (%), 2008-2020
Figure 116: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2008-2020
Figure 117: Share of the Canada Synthetic API Market by Application Sector (%), 2008-2020
Figure 118: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2008-2020
Figure 119: Revenue Share of the API Market in the US by Industry Segments (%), 2008-2020
Figure 120: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2008-2020
Figure 121: Share of the US Biotech API Market by Application Sector (%), 2008-2020
Figure 122: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2008-2020
Figure 123: Share of the US Synthetic API Market by Application Sector (%), 2008-2020
List of Tables
Table 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Table 2: Revenues of the Global Biotech API Market (in USD Million), 2008-2020
Table 3: Revenues of the Global Biotech API Market by Application Sector (in USD Million), 2008-2020
Table 4: Revenues of the Global Synthetic API Market (in USD Million), 2008-2020
Table 5: Revenues of the Global Synthetic API Market by Application Sector (in USD Million), 2008-2020
Table 6: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
Table 7: Revenues of the Biotech API Market in Asia Pacific (in USD Million), 2008-2020
Table 8: Revenues of the Biotech API Market in Asia Pacific by Application Sector (in USD Million), 2008-2020
Table 9: Revenues of the Synthetic API Market in Asia Pacific (in USD Million), 2008-2020
Table 10: Share of Revenues by Countries in Asia Pacific Synthetic API Industry (in USD Million), 2008-2020
Table 11: Revenues of the Synthetic API Market in Asia Pacific by Application Sector (in USD Million), 2008-2020
Table 12: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
Table 13: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2008-2020
Table 14: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2008-2020
Table 15: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2008-2020
Table 16: Revenues of the Active Pharmaceutical Ingredient (API) Market in India (in USD Million), 2008-2020
Table 17: Revenues of the Biotech API Market in India by Application Sector (in USD Million), 2008-2020
Table 18: Revenues of the Synthetic API Market in India by Application Sector (in USD Million), 2008-2020
Table 19: Revenues of the API Market in Japan by Industry Segmentation (in USD Million), 2008-2020
Table 20: Revenues of the Biotech API Market in Japan by Application Sector (in USD Million), 2008-2020
Table 21: Revenues of Japan Synthetic API Market by Application Sector (in USD Million), 2008-2020
Table 22: Revenues of the Active Pharmaceutical Ingredient (API) Market in South Korea (in USD Million), 2008-2020
Table 23: Revenues of the Biotech API Market in South Korea by Application Sector (in USD Million), 2008-2020
Table 24: Revenues of the Synthetic API Market in South Korea by Application Sector (in USD Million), 2008-2020
Table 25: Revenues of the Europe Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
Table 26: Revenues of the European Biotech API Market (in USD Million), 2008-2020
Table 27: Revenues of the European Biotech API Market by Application Sector (in USD Million), 2008-2020
Table 28: Revenues of the European Synthetic API Market (in USD Million), 2008-2020
Table 29: Revenues of the European Synthetic API Market by Application Sector (in USD Million), 2008-2020
Table 30: Revenue Breakdown of the API Market in Europe by Therapeutic Applications (%), 2017 & 2020
Table 31: Pricing & Reimbursement Mechanism in Top Markets in Europe, 2017
Table 32: Revenues of the Active Pharmaceutical Ingredient (API) Market in France (in USD Million), 2008-2020
Table 33: Revenues of the Biotech API Market in France by Application Sector (in USD Million), 2008-2020
Table 34: Revenues of the Synthetic API Market in France by Application Sector (in USD Million), 2008-2020
Table 35: Revenues of the Active Pharmaceutical Ingredient (API) Market in Germany (in USD Million), 2008-2020
Table 36: Revenues of the Biotech API Market in Germany by Application Sector (in USD Million), 2008-2020
Table 37: Revenues of the Synthetic API Market in Germany by Application Sector (in USD Million), 2008-2020
Table 38: Revenues of the Active Pharmaceutical Ingredient (API) Market in Italy (in USD Million), 2008-2020
Table 39: Revenues of the Biotech API Market in Italy by Application Sector (in USD Million), 2008-2020
Table 40: Revenues of the Synthetic API Market in Italy by Application Sector (in USD Million), 2008-2020
Table 41: Revenues of the Active Pharmaceutical Ingredient (API) Market in Spain (in USD Million), 2008-2020
Table 42: Revenues of the Biotech API Market in Spain by Application Sector (in USD Million), 2008-2020
Table 43: Revenues of the Synthetic API Market in Spain by Application Sector (in USD Million), 2008-2020
Table 44: Revenues of the Active Pharmaceutical Ingredient (API) Market in the UK (in USD Million), 2008-2020
Table 45: Revenues of the Biotech API Market in UK by Application Sector (in USD Million), 2008-2020
Table 46: Revenues of the Synthetic API Market in the UK by Application Sector (in USD Million), 2008-2020
Table 47: Revenues of the Active Pharmaceutical Ingredient (API) Market in North America (in USD Million), 2008-2020
Table 48: Revenues of the Biotech API Market in North America (in USD Million), 2008-2020
Table 49: Revenues of the Biotech API Market in North America by Application Sector (in USD Million), 2008-2020
Table 50: Revenues of the Synthetic API Market in North America (in USD Million), 2008-2020
Table 51: Revenues of the Synthetic API Market in North America by Application Sector (in USD Million), 2008-2020
Table 52: Revenue Breakdown of the API Market in North America by Therapeutic Applications (%), 2017 & 2020
Table 53: Drugs with Patent Expiries till 2017
Table 54: Revenues of the API Market in Canada by Industry Segmentation (in USD Million), 2008-2020
Table 55: Revenues of the Canada Biotech API Market by Application Sector (in USD Million), 2008-2020
Table 56: Revenues of the Canada Synthetic API Market by Application Sector (in USD Million), 2008-2020
Table 57: Revenues of the API Market in the US by Industry Segmentation (in USD Million), 2008-2020
Table 58: Revenues of the US Biotech API Market by Application Sector (in USD Million), 2008-2020
Table 59: Revenues of the US Synthetic API Market by Application Sector (in USD Million), 2008-2020
Companies Mentioned
- Albemarle Corporation
- Allergan Plc
- Ampac Fine Chemicals LLC
- Aptuit, Inc
- Aurobindo Pharma
- BASF SE
- Biocon Limited
- Boehringer Ingelheim GmbH
- Bristol Myers Squibb Company
- Cambrex Corporation
- Cipla Limited
- Dishman Pharmaceuticals & Chemicals Ltd.
- Dr. Reddy's Laboratories Limited
- Fabbrica Italiana Sintetici
- Koninklijke DSM N.V.
- Lonza Group AG
- Lupin Limited
- Medtronic Plc
- Mylan Inc
- Novartis AG
- Novasep Holding
- Pfizer Inc
- Ranbaxy Laboratories
- Sigma-Aldrich Corporation
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Limited
- WuXi AppTec, Inc
